School of Social Sciences, University of the West of Scotland, Paisley, UK.
Psychol Health. 2011 Jun;26(6):703-12. doi: 10.1080/08870446.2010.488265. Epub 2011 Jun 21.
Type D personality, the combination of negative affectivity (NA) and social inhibition (SI), is an emerging risk factor in cardiovascular disease. This study aimed to examine one possible behavioural mechanism to explain the link between Type D and ill-health. It was hypothesised that Type D personality would predict medication adherence in myocardial infarction (MI) patients. In a prospective study, 192 MI patients (54 females and 138 males) completed measures of Type D personality and provided demographic and medical information 1 week post-MI, and then 131 patients went on to complete a self-report measure of medication adherence 3 months post-MI. It was found that Type D personality predicts adherence to medication, after controlling for demographic and clinical risk factors. Critically, the constituent components of Type D, NA and SI, interact to predict medication adherence, after controlling for the effects of each component separately. Poor adherence to medication may represent one mechanism to explain why Type D cardiac patients experience poor clinical outcome, in comparison to non-Type D patients. Interventions, which target the self-management of medication, may be useful in these high-risk patients.
D 型人格是指消极情感(NA)和社交抑制(SI)的结合,是心血管疾病的一个新的风险因素。本研究旨在探讨一种可能的行为机制,以解释 D 型人格与健康不良之间的联系。研究假设 D 型人格会预测心肌梗死(MI)患者的药物依从性。在一项前瞻性研究中,192 名 MI 患者(54 名女性和 138 名男性)在 MI 后 1 周完成了 D 型人格量表的测量,并提供了人口统计学和医疗信息,然后有 131 名患者在 MI 后 3 个月继续完成了药物依从性的自我报告测量。研究发现,在控制人口统计学和临床风险因素后,D 型人格可以预测药物的依从性。至关重要的是,在单独控制每个组成部分的影响后,D 型人格的组成部分,即消极情感和社交抑制,相互作用可以预测药物的依从性。与非 D 型患者相比,药物依从性差可能是 D 型心脏病患者临床预后不良的原因之一。针对药物自我管理的干预措施可能对这些高风险患者有用。